APPLICATION
ANDA208075
TYPE
ANDA
ORIGINAL APPROVAL
2021-09-21
LATEST ACTION
2024-05-30
ROUTE
INTRAVENOUS
DOSAGE FORM
POWDER
MARKETING STATUS
Prescription
Products
CEFTAROLINE FOSAMILPrescription
CEFTAROLINE FOSAMIL 600MG/VIAL · POWDER · INTRAVENOUS
CEFTAROLINE FOSAMILPrescription
CEFTAROLINE FOSAMIL 400MG/VIAL · POWDER · INTRAVENOUS
Approval history
2024-05-30Labeling · Supplement 1 · standardAP
2024-05-30Labeling · Supplement 2 · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.